Recent randomized controlled trials covering several hundred patients with approximately 15-year follow-up have documented that biologic repair of subchondral lesions for patients with osteoarthritis and osteonecrosis is a viable alternative to total knee arthroplasty. Readers of this Blog should be aware that I have been performing a combined Intraarticular and Intraosseous Subchondroplasty for over six years when indicated, for the appropriate patient, and this led to a research article published in September 2020. Quoting from my publication, “knee osteoarthritis increasingly is considered to be a whole-joint disease of which the degeneration of articular cartilage is a critical component of OA pathology, along with alterations to the synovial membrane and changes to the subchondral bone supporting the cartilage.” (Sheinkop et al, J Regen Med 2020, 9:3)
The above is evidence, but patients must be aware Biologics are increasingly being marketed. Many claims are being fraudulently advanced by charlatans, camp followers, and opportunists (prostitutes). One egregious example of fraud and abuse is the patient who presented to my office after failed therapy with Wharton’s jelly for which the patient has paid out an exorbitant sum of monies to chiropractors on three occasions. The following quote speaks for itself: “A regenerative medicine doctor recently asked the CBER division of the FDA if Wharton’s Jelly products were being correctly regulated and sold for use in humans. Guess what? The FDA said “NO”. All allograft stem cell Wharton’s Jelly products currently on the market in the USA are being sold in violation of FDA regulations.”
As an evidence-based practice, I use Orthobiologics-Proprietary Platelet Rich Plasma, Adult Mesenchymal Stem Cells from your bone marrow and most recently under FDA Clinical Trial approval, from your adipose tissue, as well as Growth Factors and proteins in your circulating blood to improve outcomes for orthopedic patients. While requirements for evidence of safety and effectiveness vary greatly, in addition to FDA-approved clinical trials, leaders from the American Academy of Orthopedics Committee on Devices, Biologics & Technology are assuring compliance with the regulatory landscape. The AAOS Biologics Initiative and the Academy are investing heavily in this evolving area of medicine to protect the patient.
Schedule Your Office Visit | Evidence-Based Orthobiologics
To learn if orthobiologics and cellular orthopedics might minimize your symptoms related to arthritis and maximize your functional capacity enabling golf, cycling, running, etc. visit my website at www.sheinkopmd.com. To schedule an office consultation or even for a second opinion to learn if you might delay, perhaps avoid surgery for arthritis with a needle, not a knife, call (847) 390-7666.